![HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram](https://www.researchgate.net/publication/358437403/figure/fig2/AS:1121708148822017@1644447471123/HMBD-002-binds-with-high-affinity-and-specificity-to-a-species-conserved-epitope-on_Q320.jpg)
HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram
![HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram](https://www.researchgate.net/publication/358437403/figure/fig3/AS:1121708148826118@1644447471188/HMBD-002-demonstrates-strong-antitumor-responses-as-a-single-agent-in-multiple-CDX-models.png)
HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram
![HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram](https://www.researchgate.net/publication/358437403/figure/fig1/AS:1121708148826117@1644447471061/HMBD-002-is-a-unique-anti-VISTA-antibody-immunoengineered-to-bind-to-a-rationally_Q320.jpg)
HMBD-002 is a unique anti-VISTA antibody, immunoengineered to bind to a... | Download Scientific Diagram
![HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram](https://www.researchgate.net/publication/358437403/figure/fig3/AS:1121708148826118@1644447471188/HMBD-002-demonstrates-strong-antitumor-responses-as-a-single-agent-in-multiple-CDX-models_Q320.jpg)
HMBD-002 demonstrates strong antitumor responses as a single agent in... | Download Scientific Diagram
![SITC 2021: A Phase 1 First-in-Human study of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies | Hummingbird Bioscience SITC 2021: A Phase 1 First-in-Human study of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies | Hummingbird Bioscience](https://hummingbirdbioscience.com/wp-content/uploads/2022/11/A-Phase-1-First-in-Human-Study-of-HMBD-002-an-IgG4-Monoclonal-Antibody-Targeting-VISTA-scaled.jpg)